Viking Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Viking Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viking Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viking Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.4M | 244k | 26.28 |
| 2025-06-30 | $14M | 509k | 26.50 |
| 2025-03-31 | $11M | 470k | 24.15 |
| 2024-12-31 | $19M | 463k | 40.24 |
| 2024-09-30 | $30M | 472k | 63.31 |
| 2024-06-30 | $25M | 479k | 53.01 |
| 2024-03-31 | $29M | 356k | 82.00 |
| 2023-12-31 | $8.8M | 475k | 18.61 |
| 2023-09-30 | $5.3M | 479k | 11.07 |
| 2022-03-31 | $334k | 111k | 3.00 |
| 2021-12-31 | $511k | 111k | 4.60 |
| 2021-09-30 | $698k | 111k | 6.28 |
| 2021-06-30 | $774k | 129k | 5.99 |
| 2021-03-31 | $634k | 100k | 6.33 |
| 2020-12-31 | $420k | 72k | 5.82 |
| 2020-09-30 | $420k | 72k | 5.82 |
| 2020-06-30 | $520k | 72k | 7.21 |
| 2020-03-31 | $406k | 87k | 4.68 |
| 2019-12-31 | $702k | 88k | 8.02 |
| 2019-09-30 | $559k | 81k | 6.88 |
| 2019-06-30 | $545k | 66k | 8.30 |
| 2019-03-31 | $470k | 47k | 9.94 |
| 2018-12-31 | $205k | 27k | 7.65 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas